Link Health Group:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Link Health Group - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11337
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Link Health Group (Link Health) is a pharmaceutical company focused on the discovery and development of novel drug candidates for the treatment of cancer and other diseases. Its pipeline product portfolio includes LH011, an oral small molecule serine protease inhibitor for treating pancreatic and breast cancer; LH021 for cartilage repair; LH025, an anti-inflammatory tripeptide used for the treatments of inflammatory bowel disease as well as psoriasis; LH031, a novel small molecule inhibitor of the kinesin motor protein targeting lung and liver cancers; LH026 against Rhinitis. The company has operations with subsidiaries in China and Hong Kong. Link Health is headquartered in Guangzhou, China.

Link Health Group – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Link Health Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Link Health Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Link Health Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Link Health Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Link Health Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Link Health Group, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Link Health Raises USD8.85 Million in Series A Financing 10
Link Health Raises Funds through Venture Financing 11
Partnerships 12
Link Health Enters into Agreement with Shenzhen JYMed Tech 12
Licensing Agreements 13
Link Health Enters into Licensing Agreement with Teikoku Pharma 13
Link Health Enters into Licensing Agreement with 4SC 14
Link Health Enters into Licensing Agreement with Dr. Wolff Gruppe 15
Wilex Enters Into Licensing Agreement With Link Health For Mesupron 16
Link Health Group – Key Competitors 17
Link Health Group – Key Employees 18
Link Health Group – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Link Health Group, Pharmaceuticals & Healthcare, Key Facts 2
Link Health Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Link Health Group, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Link Health Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Link Health Group, Deals By Therapy Area, 2012 to YTD 2018 8
Link Health Group, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Link Health Raises USD8.85 Million in Series A Financing 10
Link Health Raises Funds through Venture Financing 11
Link Health Enters into Agreement with Shenzhen JYMed Tech 12
Link Health Enters into Licensing Agreement with Teikoku Pharma 13
Link Health Enters into Licensing Agreement with 4SC 14
Link Health Enters into Licensing Agreement with Dr. Wolff Gruppe 15
Wilex Enters Into Licensing Agreement With Link Health For Mesupron 16
Link Health Group, Key Competitors 17
Link Health Group, Key Employees 18
Link Health Group, Subsidiaries 19

List of Figures
Link Health Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Link Health Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Link Health Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Link Health Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Link Health Group, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Link Health Group, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Link Health Group, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Link Health Group, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Link Health Group:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Globin Solutions Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globin Solutions Inc (Globin) is a pre-clinical stage biotechnology company with focus on the research and development of antidotal medicines for human poisoning. Its lead compound, Ngb H64Q, an antidote, a mutant version of the protein neuroglobin, has been found to scavenge carbon monoxide …
  • Ferroglobe PLC (GSM):企業の財務・戦略的SWOT分析
    Ferroglobe PLC (GSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Chesapeake Energy Corporation (CHK):石油・ガス:M&Aディール及び事業提携情報
    Summary Chesapeake Energy Corp (Chesapeake) is an upstream oil and gas company in the US. The company explores for, develops and produces oil and gas from its assets. It has liquid operations in Eagle Ford Shale; the Utica Shale; the Granite Wash, Cleveland, Tonkawa and Mississippian Lime plays in t …
  • Hankyu Hanshin Holdings, Inc.:企業の戦略・SWOT・財務情報
    Hankyu Hanshin Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary Hankyu Hanshin Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Eddie Stobart Logistics plc:企業の戦略・SWOT・財務情報
    Eddie Stobart Logistics plc - Strategy, SWOT and Corporate Finance Report Summary Eddie Stobart Logistics plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Uscom Ltd. (UCM):医療機器:M&Aディール及び事業提携情報
    Summary Uscom Ltd. (Uscom) is a medical device company that operates in non-invasive hemodynamic market. It focuses on the development, design, manufacture and marketing of non-invasive cardiac monitoring devices. Uscom’s product portfolio includes its flagship product USCOM 1A (ultrasonic cardiac o …
  • Osprey Medical Inc (OSP):医療機器:M&Aディール及び事業提携情報
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • Merz Pharma GmbH & Co. KGaA:企業のM&A・事業提携・投資動向
    Merz Pharma GmbH & Co. KGaA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Merz Pharma GmbH & Co. KGaA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Teck Resources Ltd:戦略・SWOT・企業財務分析
    Teck Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Teck Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Energy Recovery Inc (ERII):企業の財務・戦略的SWOT分析
    Energy Recovery Inc (ERII) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Ray Sigorta A.S.:企業の戦略・SWOT・財務情報
    Ray Sigorta A.S. - Strategy, SWOT and Corporate Finance Report Summary Ray Sigorta A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Servest Group Ltd:企業の戦略的SWOT分析
    Servest Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Doxa AB (DOXA):医療機器:M&Aディール及び事業提携情報
    Summary Doxa AB (Doxa) is a medical device company that develops, manufactures and markets dental bioceramic products. The company’s product includes ceramir crown and bridge, which is dental cement for permanent fixtures including ceramic structures with aluminum oxide or zirconia bodies. Its bioma …
  • Shanghai ChemPartner Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai ChemPartner Co Ltd (ChemPartner) is a life science contract research organization. The organization’s services include manufacturing of small molecules and biologics, drug discovery and development, biomarkers, preclinical and clinical sample bioanalysis, and analytical services, am …
  • Mapfre Middlesea p.l.c.:企業の戦略・SWOT・財務分析
    Mapfre Middlesea p.l.c. - Strategy, SWOT and Corporate Finance Report Summary Mapfre Middlesea p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PHINMA Energy Corp (TAPET):企業の財務・戦略的SWOT分析
    Summary PHINMA Energy Corp (PHINMA), formerly Trans-Asia Oil and Energy Development Corp, is an oil and gas company that explores and develops oil and gas interest and geothermal energy. The company operates through business division such as power, wind energy, and energy resource development. Its p …
  • Fagron NV (FAGR):企業の財務・戦略的SWOT分析
    Summary Fagron NV (Fagron), formerly Arseus NV is a pharmaceutical compounding solution provider. The company offers products such as raw materials, extracts and tinctures, flammable products, anesthesia, ointment bases, syrups, suspension media, triturations, phyto pharmaflore, medispend, capsicard …
  • A.F. Blakemore & Son Ltd (Foodservice):企業の戦略・SWOT・財務情報
    A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary A.F. Blakemore & Son Ltd (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Bayer AG:企業のM&A・事業提携・投資動向
    Bayer AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Bayer AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital …
  • Metalloinvest MC LLC:企業の戦略的SWOT分析
    Metalloinvest MC LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆